Work

Evaluation of NEUROG1 methylation status in stool specimens in the advanced adenomas and colorectal cancer

Year: 2025

Type: article

Abstract: Background: To assess the status of NEUROG1 methylation in the advanced adenoma and colorectal cancer. Methods: The NEUROG1 methylation in tissue and stool samples from patients with colorectal cancer (CRC), advanced adenoma (AA), and non-advanced adenoma (NAA) were evaluated using methylation-specific quantitative polymerase chain reaction (PCR). Results: In tissue samples, the NEUROG1 methylation detection rates were 36% for CRC, 24% for NAA, and 88% for AA. In stool samples, the NEUROG1 methylation detection had a sensitivity of 63.46% for CRC with a positive predictive value (PPV) of 85.94%. The overall diagnostic specificity of the test for the NAA and the healthy control was 76.32%, with a negative predictive value (NPV) of 40.28%. Conclusion: NEUROG1 methylation detection can potentially be used in the CRC and AA screening.

Source: PeerJ

DOI: 10.7717/peerj.19968